APA (7th ed.) Citation

S, M., N, T., P, O., AL, T., M, V. D. V., C, G., . . . SS, D. (2023). Absence of Either Ripk3 or Mlkl Reduces Incidence of Hepatocellular Carcinoma Independent of Liver Fibrosis. Molecular cancer research : MCR, 21(9), 933. https://doi.org/10.1158/1541-7786.MCR-22-0820

Chicago Style (17th ed.) Citation

S, Mohammed, et al. "Absence of Either Ripk3 or Mlkl Reduces Incidence of Hepatocellular Carcinoma Independent of Liver Fibrosis." Molecular Cancer Research : MCR 21, no. 9 (2023): 933. https://doi.org/10.1158/1541-7786.MCR-22-0820.

MLA (9th ed.) Citation

S, Mohammed, et al. "Absence of Either Ripk3 or Mlkl Reduces Incidence of Hepatocellular Carcinoma Independent of Liver Fibrosis." Molecular Cancer Research : MCR, vol. 21, no. 9, 2023, p. 933, https://doi.org/10.1158/1541-7786.MCR-22-0820.